NCI unveils comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries
NCI’s Clinical Proteomic Tumor Analysis Consortium releases proteogenomic dataset to accelerate cancer discoveries.
NIH study offers insights into how cells reverse their decision to divide
An NCI study shows that cell division can be interrupted by withdrawing growth-promoting signals early on in the process.
Biden-Harris Administration launches initiative to improve cancer outcomes in low-income areas
NCI has awarded $50 million to establish five new centers to study interventions for improving cancer outcomes in persistent poverty communities.
NCI’s ComboMATCH initiative will test new drug combinations guided by tumor biology
ComboMATCH will consist of numerous phase 2 cancer treatment trials that aim to identify promising drug combinations that can advance to larger, more definitive clinical trials.